Etoposide-initiated MLL rearrangements: the pitfalls of  inverse PCR.
Barjesteh van Waalwijk van Doorn-Khosrovani
Sahar
S
Vanhees
Kimberly
K
Ruijters
Erik
E
van Schooten
Frederik-Jan
FJ
D000818:Animals; D018952:Antigens, CD34 / Q000187:drug effects / Q000276:immunology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001483:Base Sequence; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D002869:Chromosome Aberrations / Q000139:chemically induced*; D005047:Etoposide / Q000009:adverse effects*; D020869:Gene Expression Profiling; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D008055:Lipids / Q000096:biosynthesis; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D018613:Microscopy, Confocal; D008969:Molecular Sequence Data; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D016133:Polymerase Chain Reaction / Q000379:methods
D018952:Antigens, CD34; D000970:Antineoplastic Agents; D008055:Lipids; D051788:Myeloid-Lymphoid Leukemia Protein; D005047:Etoposide